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During the last decades, assisted reproduction has found
wide application in cattle, but with increasing manipula-
tion of the embryos the mortality of the fetus and off-
spring have been shown to increase. Manipulation of
early embryos induces subtle modifications of the devel-
opmental capacity resulting in changes of the maternal-
embryonic interaction and the fetal adaptation and in
abnormalities, which become apparent during pregnancy
and delivery.
By definition, assisted reproductive techniques in the
bovine include ET, MOET, IVP and cloning [1-3]:
Embryo transfer (ET) is the process of transferring
embryos from donors to recipients which are synchro-
nised to the appropriate day after heat. Embryos for trans-
fer can either be developed in vivo (MOET) or in vitro
(IVF).
MOET (multiple ovulations and embryo transfer) is the
technology which is used worldwide to produce 80% of
embryos for commercial purposes. The embryos are pro-
duced by superovulation of the donor cow with eCG or
FSH, which are administered in the mid-luteal phase of
the estrus cycle of the donor over a 3 to 4 days period and
are combined with induced luteolysis and estrus. The
donor is inseminated during estrus, and 7 days later the
uterus is flushed to recover on average four to six transfer-
able good quality embryos. Half of the commercially pro-
duced embryos are transferred fresh and the other half is
frozen for later transfer.
IVP is the in vitro production of embryos where immature
oocytes are recovered from the ovaries in the live cow by
transvaginal aspiration, so called OPU (ovum pick-up)
using an ultrasound scanner equipped with a transducer
and a guided needle. Alternatively, when the female
parental origin is not required to be known, the oocytes
are collected from slaughterhouse ovaries. Several culture
protocols can be used to mature, fertilize and culture the
oocytes for about one week to blastocyst stage which is
suitable for transfer or freezing. IVP embryos contribute
with 20% to the commercially transferred embryos, which
are mainly transferred freshly. Pregnancy rates are gener-
ally about 40–45% after fresh transfers, but become more
variable amongst different laboratories with frozen
embryos.
Cloning is the process of fusing a donor cell (often a dif-
ferentiated cell from an adult) with an oocyte, from which
the nucleus, containing the DNA, has been removed.
Under this process, the genome of the donor cells is trans-
ferred to the recipient oocyte and reprogrammed to the
status of an undifferentiated cell, which can undergo
embryonic development. Thus, genetically identical off-
spring of already existing individuals can be created. Cells
harvested from preimplantation embryos, fetuses or adult
animals – typically fibroblasts, cumulus and granulosa
cells or mammary epithelial cells (Dolly) – can be used to
produce these clones. The efficiency is still low and only
about 5% of the cloned bovine blastocysts transferred to
recipients survive to term. So far, 12 different animal spe-
cies have been cloned, but cloning has not yet become
commercially important. This technology may, however
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Mortality during pregnancy
In vitro produced and cloned embryos are acutely sensi-
tive to environmental conditions, but adverse repercus-
sions of such sensitivities may not be manifest, until
much later in development and the long-term conse-
quences may have different times of sensitivity within the
developing embryo. Conceptuses, fetuses and offspring
resulting from those embryos can differ in their viability,
morphology and physiology compared with in vivo con-
trols [4-8]. A better understanding of these mechanisms
will not only facilitate the refinement of IVP and cloning
systems, but may also improve our management of preg-
nant animals.
After transfer of cloned embryos, 60% or more of the preg-
nancies are lost in the first trimester of pregnancy. This is
followed by a small but constant loss of the remaining
pregnancies up to the 8 months, which is an unusual pat-
tern in the extent and timing of pregnancy loss. These
pregnancy losses can be attributed to a defective placental
function, as demonstrated by an initial reduction of coty-
ledon development. Later in the pregnancy the abortions
are associated with placenta hypertrophy, enlarged cotyle-
dons and thickening of the umbilical cord [9-11].
Under certain culture conditions (coculture and use of
serum-supplemented medium) IVP embryos and cloned
embryos may develop large offspring syndrome (LOS), in
which late fetal losses are associated with excess fetal size,
abnormal placental development and vasculature (i.e.
hydroallantois, enlarged edematous placentomes in
reduced numbers), extremely large umbilical veins and
arteries and abnormal, asynchronous growth of organs
with musculoskeletal deformities. Overall, there is a
higher incidence of LOS in clones compared to in vitro
derived embryos, and especially in clones produced from
somatic cells compared with clones produced from
embryonic cells [7,10,12-14].
Chromosomal abnormalities are a well-known cause of
pregnancy failure and chromosomally abnormal cells are
commonly found in IVP or cloned embryos. However, the
frequency reported varies with the method of embryo pro-
duction. The most frequently observed deviation from the
diploid karyotype is mixoploidy resulting from aberrant
cell division causing polyploidy in a variable proportion
of an embryo's cells [15,16].
Mortality at delivery
Most of the born calves derived from in vitro produced
embryos appear normal, but a number of deviations have
been reported that together have been termed as LOS.
These include weak labor in the recipients, extended ges-
tation, dystocia, increased incidence of hydrallantois, con-
genital malformations, increased birth weight and higher
incidence of perinatal mortality. Live offspring occasion-
ally exhibit heart insufficiency and respiratory distress
with pulmonary hypertension. A wide range of other ill-
nesses have been reported in clones, including infections,
somatic overgrowth and omphalocele. Apparently normal
clones show physiologic particularities such as alterations
in temperature regulation and increased abdominal fat
and leptin concentrations. Some of these calves require
considerable intensive care to support their initial survival
[10,11,17-23].
One possible approach to reduce the perinatal morbidity/
mortality of offspring derived from assisted reproductive
technologies is to provide the appropriate assistance dur-
ing delivery. A number of procedures such as inducing
parturition have been developed for this purpose; how-
ever, these protocols did not significantly reduce parturi-
ent and neonatal disorders following transfer of IVP or NT
embryos [24]. Even when the adverse effects of dystocia
are prevented by cesarean section, prenatal problems per-
sist and evidence suggests that these are consequences of
energy metabolism defects resulting from placental insuf-
ficiency. The majority of parturient complications may be
explained by an inadequate signaling between mother
and fetus associated with deficiencies in the establishment
of placental vasculature.
Until an age of 5 months, the mortality of cloned calves is
up to 40% [25] and between weaning and 4 years of age,
the annual mortality rate in cattle cloned from somatic
cells is approximately 10%. The LOS is the consequences
of abnormal programming occurring during early embry-
onic development, which becomes manifest throughout
gestation, the neonatal period and during adulthood in
the cloned animal, but it does not appear to be transmit-
ted to subsequent offspring following sexual reproduction
[26,27].
The increased perinatal mortality in calves born after
assisted reproduction involves ethical and economic con-
cerns which have to be attended solved if the methods are
to be used for commercial purposes such as breeding and
production of transgenic animals for pharmaceutical pro-
duction.
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